aromasil has been researched along with Pregnancy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Davies, HM; Egbuta, C; Ghosh, D; Griswold, J; Hubbell, S; Jiang, W; Lo, J; Morton, D; Valette, D; Xi, J | 1 |
| Cohen, PR | 1 |
| Burns-Naas, LA; Cappon, GD; Chapin, RE; Hurtt, ME; Wajnrajch, MP | 1 |
| Learman, LA | 1 |
| Briatico, G; D'Alessio, R; Di Salle, E; Giudici, D; Lombardi, P; Ornati, G; Villa, V | 1 |
| Briatico, G; di Salle, E; Giudici, D; Ornati, G; Zaccheo, T | 1 |
| Briatico, G; Buzzetti, F; di Salle, E; Giudici, D; Lombardi, P; Ornati, G | 1 |
7 other study(ies) available for aromasil and Pregnancy
| Article | Year |
|---|---|
Novel aromatase inhibitors by structure-guided design.
Topics: Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Molecular Docking Simulation; Molecular Structure; Placenta; Pregnancy; Protein Binding; Stereoisomerism; Structure-Activity Relationship | 2012 |
Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genetic Predisposition to Disease; Humans; Hyperpigmentation; Letrozole; Male; Melanosis; Neovascularization, Pathologic; Nitriles; Pregnancy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Ultraviolet Rays; Vascular Endothelial Growth Factor A | 2017 |
Impaired reproduction in adult male, but not female, rats following juvenile treatment with the aromatase inhibitor, exemestane.
Topics: Abnormalities, Drug-Induced; Androstadienes; Animals; Aromatase Inhibitors; Body Weight; Female; Fertility; Male; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Sertoli Cells; Sexual Maturation | 2011 |
What is new in primary care? Best articles from the past year.
Topics: Alzheimer Disease; Androstadienes; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Contraception; Dementia, Vascular; Diphosphonates; Estrogens, Conjugated (USP); Female; Femoral Fractures; Humans; Mass Screening; Ovarian Neoplasms; Pregnancy; Pregnancy in Diabetics; Primary Health Care; Randomized Controlled Trials as Topic; Smoking; Stroke | 2012 |
4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
Topics: Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Male; Pregnancy; Rats; Rats, Inbred Strains | 1990 |
Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Female; Humans; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Microsomes; Orchiectomy; Ovary; Pargyline; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Reference Values | 1989 |
6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
Topics: Androstadienes; Animals; Aromatase Inhibitors; Female; Humans; Kinetics; Male; Microsomes; Ovary; Placenta; Pregnancy; Prostate; Rats; Receptors, Androgen; Receptors, Estrogen; Uterus | 1988 |